Gosset Ownership
Private
Employees
~10
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Athena Bioscience General Information
Athena Bioscience has achieved FDA approval for QDOLO™ (tramadol hydrochloride oral solution), indicated for the management of severe pain in adults when alternative treatments are inadequate. Other programs include previously approved or withdrawn drugs targeting hypertension and hypertriglyceridemia.
Contact Information
Primary Industry
Biotech
Corporate Office
Athens, Georgia
United States
United States
Drug Pipeline
tramadol
CommercialKey Partnerships
Athena Bioscience Funding
No funding data available
To view Athena Bioscience's complete valuation and funding history, request access »